Compositions and methods useful for HCV infection

Details Compositions and methods useful for HCV infection Compositions and methods useful for HCV infection

2011-02-01

2011-02-01

Angell, J. E (Department: 1635)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Primate cell, per se

Reexamination Certificate

active

07879606

ABSTRACT:
The present invention provides compositions comprising cells that can effectively produce HCV after HCV infection, compositions for culturing the cells, methods for making the composition and methods for infecting the cells in the composition with HCV. The present invention also provides methods for assaying HCV production and methods for evaluating compounds that affect the production of HCV.

REFERENCES:
patent: 5529920 (1996-06-01), Cole et al.
patent: 5576207 (1996-11-01), Reid
patent: 5789246 (1998-08-01), Reid
patent: 5849686 (1998-12-01), Kuberasampath et al.
patent: 6069005 (2000-05-01), Reid
patent: 6127116 (2000-10-01), Rice et al.
patent: 6146889 (2000-11-01), Reid
patent: 6242252 (2001-06-01), Reid
patent: 7183095 (2007-02-01), Dasgupta et al.
patent: 2001/0023073 (2001-09-01), Bhatia et al.
patent: 2001/0043919 (2001-11-01), Reid et al.
patent: 2002/0016000 (2002-02-01), Reid et al.
patent: 2002/0039786 (2002-04-01), Reid et al.
patent: 2002/0187133 (2002-12-01), Kubota et al.
patent: 2004/0167067 (2004-08-01), Griggs et al.
patent: 1421222 (2004-05-01), None
patent: 2004-537279 (2004-12-01), None
patent: WO 93/03142 (1993-02-01), None
patent: WO 95/13697 (1995-05-01), None
patent: WO 99/67362 (1999-12-01), None
patent: WO 00/34507 (2000-06-01), None
patent: WO 00/43498 (2000-07-01), None
patent: WO 02/28997 (2002-04-01), None
patent: WO 02/29012 (2002-04-01), None
patent: WO 01/53462 (2002-07-01), None
patent: WO 02/072776 (2002-09-01), None
Gilbert, S. Developmental Biology, 6th Edition (2000).
Fournier et al., “In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus”,Journal of General Virology, vol. 79, pp. 2367-2374 (1998).
Rumin et al., “Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro”,Journal of General Virology, vol. 80, pp. 3007-3018 (1999).
Aparicio, P. et al. Isolation and characterization of (gamma delta) CD4+ T cell clones derived from human fetal liver cells.Journal of Experimental Medicine, (1989) vol. 170 pp. 1009-1014.
Iacovacci, S. et al. Molecular Characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro.Hepatology, (1997) vol. 26(5) pp. 1328-1337.
Ochiya, T. et al. An in vitro system for infection with hepatitis B virus that uses primary human fetal hepatocytes.Proc. Natl. Acad. Sci. USA, (1989) vol. 86 pp. 1875-1879.
Susick et al., “Hepatic Progenitors and Strategies for Liver Cell Therapies for Liver Cell Therapies,” Ann. NY Acad. Sci., 944:398-419 (2001).
M. Chessebeuf, et al., “Rat liver epithelial cell cultures in a serum-free medium: primary cultures and derived cell lines expressing differentiated functions,” In Vitro, 20(10), pp. 780-795 (1984).
C. Clarysse et al., “In vitro assays for drug testing: continuous cell lines,”Acta Gastro-Enterologica Belgica, 63, pp. 213-215 (2000).
G. Carloni, et al., “Susceptibility of human liver cell cultures to hepatitis C virus infection,”Arch. Virol., 8, pp. 31-39 (1993).
S. Iacovacci, et al., “Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro,”Hepatology, 26(5) pp. 1328-1337 (1997).
H. Kubota et al., “Clonogenic hepatoblasts, common precursors for hepatocyctic and biliary lineages, are lacking classical major histocompatibility complex class 1 antigen,”PNAS, 97(22), pp. 12132-12137 (2000).
A. Morrica, et al., “Susceptibility of human and non-human cell lines to HCV infection as determined by the centrifugation-facilitated method,”Journal of Virological Methods, 77, pp. 207-215 (1999).
M. Salas-Prato, et al., “Attachment and multiplication, morphology and protein production of human fetal primary liver cells cultured in hormonally defined media,”In Vitro Cellular&Developmental Biology, 24(3), pp. 230-238 (1988).
S. Seipp, et al., “Establishment of persistent hepatitis C virus infection and replication in vitro,”Journal of General Virology, 78, pp. 2467-2476 (1997).
B.J. Yoo, et al, “Transfection of a differentiated human hepatoma cell line (Huh7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCV,”Journal of Virology, 69(1), pp. 32-38 (1995).
S. Iacovacci, et al., “Replication and multiplication of hepatitis C virus genome in human foetal liver cells,” Res. Virol. 144, pp. 275-279 (1993).
T. Ito, et al., “Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titre infectious virus,” Journal of General Virology, vol. 77, pp. 1043-1054 (1996).
Levesque,Use of serum-free media to minimize apoptosis of chronic lymphocytic leukemia cells during in vitro culture, Leukemia 2001, pp. 1305-1307.
Harlow et al.Antibodies: A Laboratory Manual(1988) Cold Spring Harbor Laboratory, pp. 349, 406-407; LSAB2 kit of DAKO Corporation.
Teratocarcinomas and Embryonic Stern Cells: A Practical Approach, ed. Robertson, E.J. (IRS, Oxford), pp. 71-112.
Methods for Tissue Engineering, Ed. Robert Lanza, Academic Press, NY (2002), pp. 151-202.

Affiliated with

Also associated with

Rating

Compositions and methods useful for HCV infection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods useful for HCV infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods useful for HCV infection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2634199